Rhianon Ebsworth
Senior Corporate Counsel, Novo Nordisk
Rhianon is lead attorney responsible for providing legal advice in respect of clinical development and regulatory matters within Novo Nordisk globally as well as advising the device development and clinical supply areas. She supports all areas of clinical development for Novo Nordisk including: clinical operations from Phases I to IV, including non-interventional studies, investigator sponsored studies, and usability studies, pre-clinical development, regulatory matters, data privacy and more.
Rhianon joined Novo Nordisk in January 2010 and currently lives and works in Copenhagen, Denmark. However, she previously spent 3 years working as Legal Counsel in the UK Affiliate of Novo Nordisk providing legal support on market activities including distribution, sales and marketing and market access in the UK and Ireland. She also has expertise in competition law, data privacy, product liability, global safety and employment law and is UK qualified solicitor.
In 2011-2, she has also spent time working in Novo Nordisk’s US HQ in Princeton, supporting the US BioPharm marketing, and Medical Affairs teams.
She has previously worked for both Sanofi-Aventis and ExxonMobil in the UK.